Mesothelioma Treatment
Mesothelioma Cancer
- Causes of Mesothelioma
- Mesothelioma Symptoms
- Mesothelioma Diagnosis
- Mesothelioma Stages
- Mesothelioma Treatment
- Innovative Mesothelioma Treatments
- Managing Mesothelioma Pain
- Nutrition Information for Mesothelioma Patients
- Specialized Mesothelioma Care
- Mesothelioma Risks
- Mesothelioma Support Groups
- Find a Mesothelioma Attorney
- Mesothelioma News
Mesothelioma Directory
Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura
Get Help Today
Looking for help or additional information? Contact us today.| Conditions: | Esophageal Cancer|Lung Cancer|Malignant Mesothelioma|Metastatic Cancer |
| Start Date: | October 1, 1999 |
| Phase: | Phase I |
| Status: | Completed |
| NCT ID: | NCT00019825 |
| Study Type: | Interventional |
| Intervention: | Drug: decitabine |
| Study Design: | Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | National Cancer Institute (NCI) |
| Ages: | Adult|Senior |
| Enrollment: | 0 |
| Funded By: | NIH |
| First Received: | July 11, 2001 |
| End Date: | |
| Last Updated: | December 13, 2008 |
| Last Verified: | July 1, 2004 |